NAL Pharmaceuticals Ltd. - Product Pipeline Review - 2015

  • ID: 3387866
  • Company Profile
  • 41 pages
  • Global Markets Direct
1 of 3
NAL Pharmaceuticals Ltd. - Product Pipeline Review - 2015

Summary

The report ‘NAL Pharmaceuticals Ltd. - Product Pipeline Review - 2015’, provides an overview of the NAL Pharmaceuticals Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NAL Pharmaceuticals Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of NAL Pharmaceuticals Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of NAL Pharmaceuticals Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the NAL Pharmaceuticals Ltd.’s pipeline products

Reasons to buy

- Evaluate NAL Pharmaceuticals Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of NAL Pharmaceuticals Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the NAL Pharmaceuticals Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of NAL Pharmaceuticals Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of NAL Pharmaceuticals Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of NAL Pharmaceuticals Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 3
List of Tables
List of Figures
NAL Pharmaceuticals Ltd. Snapshot
NAL Pharmaceuticals Ltd. Overview
Key Information
Key Facts
NAL Pharmaceuticals Ltd. - Research and Development Overview
Key Therapeutic Areas
NAL Pharmaceuticals Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
NAL Pharmaceuticals Ltd. - Pipeline Products Glance
NAL Pharmaceuticals Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
NAL Pharmaceuticals Ltd. - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
NAL Pharmaceuticals Ltd. - Drug Profiles
pegfilgrastim
Product Description
Mechanism of Action
R&D Progress
diclofenac sodium
Product Description
Mechanism of Action
R&D Progress
donepezil hydrochloride
Product Description
Mechanism of Action
R&D Progress
donepezil hydrochloride Patch
Product Description
Mechanism of Action
R&D Progress
formoterol fumarate
Product Description
Mechanism of Action
R&D Progress
galantamine hydrobromide
Product Description
Mechanism of Action
R&D Progress
indomethacin
Product Description
Mechanism of Action
R&D Progress
ketoprofen
Product Description
Mechanism of Action
R&D Progress
levocetirizine dihydrochloride
Product Description
Mechanism of Action
R&D Progress
montelukast sodium
Product Description
Mechanism of Action
R&D Progress
NAL-3216
Product Description
Mechanism of Action
R&D Progress
NAL-3221
Product Description
Mechanism of Action
R&D Progress
NAL-3223
Product Description
Mechanism of Action
R&D Progress
nicotine
Product Description
Mechanism of Action
R&D Progress
rizatriptan benzoate
Product Description
Mechanism of Action
R&D Progress
sildenafil citrate
Product Description
Mechanism of Action
R&D Progress
sufentanil citrate
Product Description
Mechanism of Action
R&D Progress
tadalafil
Product Description
Mechanism of Action
R&D Progress
tulobuterol
Product Description
Mechanism of Action
R&D Progress
NAL Pharmaceuticals Ltd. - Pipeline Analysis
NAL Pharmaceuticals Ltd. - Pipeline Products by Target
NAL Pharmaceuticals Ltd. - Pipeline Products by Route of Administration
NAL Pharmaceuticals Ltd. - Pipeline Products by Molecule Type
NAL Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action
NAL Pharmaceuticals Ltd. - Dormant Projects
NAL Pharmaceuticals Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
NAL Pharmaceuticals Ltd., Key Information
NAL Pharmaceuticals Ltd., Key Facts
NAL Pharmaceuticals Ltd. - Pipeline by Indication, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2015
NAL Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2015
NAL Pharmaceuticals Ltd. - Preclinical, 2015
NAL Pharmaceuticals Ltd. - Unknown, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Target, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2015
NAL Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2015
NAL Pharmaceuticals Ltd. - Dormant Developmental Projects,2015

List of Figures
NAL Pharmaceuticals Ltd. - Pipeline by Top 10 Indication, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2015
NAL Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Top 10 Target, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Top 10 Route of Administration, 2015
NAL Pharmaceuticals Ltd. - Pipeline by Top 10 Molecule Type, 2015
NAL Pharmaceuticals Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll